Picture of Nuformix logo

NFX Nuformix News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

REG - Nuformix PLC - Director/PDMR Shareholding

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220131:nRSe1883Aa&default-theme=true

RNS Number : 1883A  Nuformix PLC  31 January 2022

 

31 January 2022

Nuformix plc

 

("Nuformix" or the "the Company")

 

Director/PDMR Shareholding

 

Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet
medical needs in fibrosis and oncology via drug repurposing, announces that it
has granted a total of 3,000,000 warrants each to Dr Alastair Riddell, Dr
Julian Gilbert and Maddy Kennedy with an exercise price of 1.45p per share.

 

- Ends -

 

 Enquiries:

 Nuformix plc                                            via Walbrook
 Dr Alastair Riddell, Executive Chairman

 Allenby Capital Limited                                 +44 (0) 20 3328 5656
 Nick Athanas / George Payne (Corporate Finance)
 Stefano Aquilino / Matt Butlin (Sales and Corporate Broking)

 Walbrook PR        nuformix@walbrookpr.com (mailto:nuformix@walbrookpr.com)  or +44 (0)20 7933
                    8780
 Anna Dunphy / Phillip Marriage        Tel: +44 (0)7876 741 001 / +44 (0)7867 984 082

 

 

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Dr Alastair Riddell

 2    Reason for the notification

 a)   Position/status                                              PDMR - Executive Chairman

 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Nuformix plc

 b)   LEI                                                          2138003XG3H3I2J3BJ24

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Warrants to acquire ordinary shares at a price of 1.45p per share.

      Identification code

                                                                   GB00BYW79Y38
 b)   Nature of the transaction                                    Granting of warrants

 c)   Price(s) and volume(s)

Price(s)  Volume(s)

                                                                   0    3,000,000

 d)   Aggregated information                                       Single Transaction

 e)   Date of the transaction                                      31 January 2022

 f)   Place of the transaction                                     Off-market transaction

d)

 

Aggregated information

Single Transaction

 

e)

 

Date of the transaction

 

31 January 2022

f)

 

Place of the transaction

 

Off-market transaction

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Dr Julian Gilbert

 2    Reason for the notification

 a)   Position/status                                              PDMR - Non-executive Director

 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Nuformix plc

 b)   LEI                                                          2138003XG3H3I2J3BJ24

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Warrants to acquire ordinary shares at a price of 1.45p per share.

      Identification code

                                                                   GB00BYW79Y38
 b)   Nature of the transaction                                    Issue of warrants

 c)   Price(s) and volume(s)

Price(s)  Volume(s)

                                                                   0    3,000,000

 d)   Aggregated information                                       Single Transaction

 e)   Date of the transaction                                      31 January 2022

 f)   Place of the transaction                                     Off-market transaction

d)

 

Aggregated information

Single Transaction

 

e)

 

Date of the transaction

 

31 January 2022

f)

 

Place of the transaction

 

Off-market transaction

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Maddy Kennedy

 2    Reason for the notification

 a)   Position/status                                              PDMR - Non-executive Director

 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Nuformix plc

 b)   LEI                                                          2138003XG3H3I2J3BJ24

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Warrants to acquire ordinary shares at a price of 1.45p per share.

      Identification code

                                                                   GB00BYW79Y38
 b)   Nature of the transaction                                    Issue of Warrants

 c)   Price(s) and volume(s)

Price(s)  Volume(s)

                                                                   0    3,000,000

 d)   Aggregated information                                       Single Transaction

 e)   Date of the transaction                                      31 January 2022

 f)   Place of the transaction                                     Off-market transaction

d)

 

Aggregated information

Single Transaction

 

e)

 

Date of the transaction

 

31 January 2022

f)

 

Place of the transaction

 

Off-market transaction

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHWPUMUGUPPGCG

Recent news on Nuformix

See all news